Sinopharm Group Co. Ltd.
1099
株式のランク
#2933
Sinopharm Group Co. Ltd. is a prominent player in the People's Republic of... Sinopharm Group Co. Ltd. is a prominent player in the People's Republic of China's healthcare market, specializing in the wholesale and retail of pharmaceuticals, medical devices, and related health products. The company's business activities are organized across four main divisions. Its Pharmaceutical Distribution segment supplies pharmaceutical goods to a wide range of clients, including hospitals, fellow distributors, retail pharmacies, and clinics. This division additionally offers extensive distribution, logistics, and value-added support to both domestic and international manufacturers and suppliers in the pharmaceutical and healthcare sectors. The Medical Devices segment is solely focused on the distribution of various medical equipment. Through its Retail Pharmacy division, Sinopharm manages and franchises a vast chain of drug stores, with an impressive 10,259 locations as of December 31, 2021. The "Other Business" segment is involved in the manufacturing and sale of pharmaceutical products, chemical reagents, and laboratory supplies. Beyond these core areas, the company also engages in property rental and management. It further distributes specialized items such as medical instruments, traditional Chinese herbal medicines, antibiotics, and biological products. Sinopharm provides a comprehensive array of services, including IT development, medicine and health consultations, investment services, import/export facilitation for goods and technology, various business and market information consulting, and the organization of conventions and exhibitions. Moreover, it oversees medical project investments, offers related consulting, and provides technological training. Notably, Sinopharm Group has established a strategic alliance with I-Mab to enhance its commercial capabilities and accelerate its market entry strategies. Founded in Shanghai, China, in 2003, Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.
株価
$2.01
最終同期: 2026-10-16
時価総額
$6.28B
変化（1日）
0.45%
変化（1年）
-15.15%
国
CN
取引 Sinopharm Group Co. Ltd. (1099)
カテゴリー
Healthcare
Sinopharm Group Co. Ltd.（1099）の営業利益率
October 2026 時点の営業利益率 TTM: 2.95%
Sinopharm Group Co. Ltd. の最新の財務報告と株価によると、現在の営業利益率（TTM）は 2.95% です。2023 年末時点では 3.39% でした。
Sinopharm Group Co. Ltd. の営業利益率の履歴（2006 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 2.95% | 6.50% |
| 2024 | 2.77% | -18.29% |
| 2023 | 3.39% | -9.12% |
| 2022 | 3.73% | -1.32% |
| 2021 | 3.78% | -2.83% |
| 2020 | 3.89% | 2.64% |
| 2019 | 3.79% | -15.21% |
| 2018 | 4.47% | 3.95% |
| 2017 | 4.30% | 8.59% |
| 2016 | 3.96% | -1.74% |
| 2015 | 4.03% | 2.81% |
| 2014 | 3.92% | 7.69% |
| 2013 | 3.64% | 1.68% |
| 2012 | 3.58% | 0.56% |
| 2011 | 3.56% | 2.30% |
| 2010 | 3.48% | 5.45% |
| 2009 | 3.30% | 7.49% |
| 2008 | 3.07% | 20.87% |
| 2007 | 2.54% | 25.74% |
| 2006 | 2.02% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 1.62% | -99.45% |
US
|
|
| 0.00% | - |
US
|
|
| 1.03% | -99.65% |
US
|
|
| 0.00% | - |
US
|
|
| 9.21% | -96.88% |
AU
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。